Checchi Capital Advisers, LLC Viatris Inc Transaction History

Checchi Capital Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$9.02 - $10.29 $11,924 - $13,603	-1,322 Reduced 11.15%	10,530 $105,000
Q1 2023 May 05, 2023	SELL	$9.2 - $12.26 $4,075 - $5,431	-443 Reduced 3.6%	11,852 $114,000
Q4 2022 Feb 10, 2023	BUY	$8.72 - $11.56 $8,772 - $11,629	1,006 Added 8.91%	12,295 $136,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $5,274 - $6,922	-622 Reduced 5.22%	11,289 $96,000
Q2 2022 Aug 11, 2022	BUY	$9.95 - $12.27 $118,514 - $146,147	11,911 New	11,911 $115,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Checchi Capital Advisers, LLC with notifications on news.